3:27 PM
 | 
Jan 08, 2018
 |  BC Extra  |  Company News

Regeneron leads big data sequencing effort

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced a consortium of six biotech and pharmas to speed up exome sequencing of genetic data from samples in the UK Biobank.

UK Biobank debuted in 2012 with blood, urine and saliva samples donated by 500,000 volunteer participants whose health would be followed over time (see BioCentury Extra, March 30, 2012).

Regeneron, AbbVie Inc. (NYSE:ABBV), Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), AstraZeneca...

Read the full 302 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >